The 9 EU-based Billion-Euro Biotechs you Should (really) Know

15/09/2015 - 6 minutes

Update 22/10/2015: I added Galapagos from Belgium and Basilea from Switzerland, they deserved it …

Talking about billon-dollar companies in the US is such a hype. Even the Wall street journal has its own start-up club (which btw is stunning). By looking at it, I wondered which European Biotechs were worth over €1Bn in Europe. Not so many actually, but here is my now top 9 with data from our map and my personal comment for each.

N°1: Cellectis – the French CAR-T miracle

Market cap: €1.03Bn

Founded: 1999

City: Paris, France

Mission: Cellectis develops innovative cancer products based on engineered T cells armed with a Chimeric Antigen Receptor (CAR) to target liquid and solid tumor.

Related Content

Comment: Great entrepreneurial success-story that almost died two years ago. It was saved by Servier, and is now one of the leaders of the CAR-T field. Even more, it’s actually the only major CAR-T player which tries to industrialize its therapy by being able to give engineered lymphocytes to any patient instead of taking the patient’s own cells.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

You might also be interested in the following: